Previous 10 | Next 10 |
Conference call to be held Thursday October 10 th at 5:00PM EST NEW HAVEN, CT / ACCESSWIRE / October 2, 2019 / Specialty diagnostics company Precipio, Inc. ( NASDAQ:PRPO ), will hold a shareholder update call where CEO Ilan Danieli will discuss the company's commercial progress. The...
NEW HAVEN, Conn., Sept. 30, 2019 (GLOBE NEWSWIRE) -- Specialty diagnostics company Precipio, Inc. ( NASDAQ: PRPO ), announced that Tennessee Oncology has selected Precipio’s HemeScreen RUO assay as its molecular testing assay for hematologic malignancies such as myelodyspla...
Gainers: LATAM Airlines Group (NYSE: LTM ) +30% . Just Energy Group (NYSE: JE ) +26% . Tetraphase Pharmaceuticals, Inc. (NASDAQ: TTPH ) +20% . Tiziana Life Sciences PLC (NASDAQ: TLSA ) +20% . Contango Oil & Gas Company (NYSEMKT: MCF ) +14% . Ra Medical Systems, Inc. (NYSE: R...
The9 (NASDAQ: NCTY ) +34% on selling several subsidiaries to Kapler. More news on: The9 Limited, LATAM Airlines Group S.A., Applied Genetic Technologies Corporation, Stocks on the move, Read more ...
Gainers : Precipio (NASDAQ: PRPO ) +68% . Marinus Pharmaceuticals (NASDAQ: MRNS ) +15% . SAExploration Holdings (NASDAQ: SAEX ) +13% . Sonim Technologies (NASDAQ: SONM ) +13% . Aehr Test Systems (NASDAQ: AEHR ) +13% . Contango Oil & Gas Company (NYSEMKT: MCF ) +12% . Sundance Ene...
Orders expected from several major labs both domestically and internationally NEW HAVEN, Conn., Sept. 26, 2019 (GLOBE NEWSWIRE) -- Specialty diagnostics company Precipio, Inc. ( NASDAQ: PRPO ), announced that as it approaches the end of Q3-2019, several of the large la...
NEW HAVEN, Conn., Sept. 05, 2019 (GLOBE NEWSWIRE) -- Specialty Diagnostics company Precipio, Inc . ( NASDAQ: PRPO ), announced today a major development toward expanding cancer patient access to world class pathology diagnostics through a new joint collaboration with the Department of...
Precipio, Inc. (PRPO) Q2 2019 Earnings Conference Call August 21, 2019, 17:00 ET Company Participants Ilan Danieli - CEO Carl Iberger - CFO Conference Call Participants Presentation Operator Welcome to the Precipio Incorporated Second Quarter 2019 Corporate Update Cal...
Precipio (NASDAQ: PRPO ): Q2 GAAP EPS of -$1.05. Revenue of $0.94M (+14.6% Y/Y) 10-Q More news on: Precipio, Inc., Earnings news and commentary, Tech stocks news, ,
NEW HAVEN, Conn., Aug. 13, 2019 (GLOBE NEWSWIRE) -- Specialty cancer diagnostics company Precipio, Inc. ( NASDAQ: PRPO ), today announced the results of three key performance metrics that together demonstrate the continued growth and positive impact of the sales force’s expansi...
News, Short Squeeze, Breakout and More Instantly...
NEW HAVEN, Conn., July 17, 2024 (GLOBE NEWSWIRE) -- Specialty cancer diagnostics company Precipio, Inc. (NASDAQ: PRPO) , announces that for Q2-2024, its unaudited revenues have grown from $3.4M in Q1-2024 to $4.4M in Q2-2024, an increase of 30% from one quarter ago. Patholog...
NEW HAVEN, Conn., June 13, 2024 (GLOBE NEWSWIRE) -- Specialty diagnostics company Precipio, Inc. (NASDAQ: PRPO) , today announced that the company’s 2024 Annual Meeting of Shareholders (“Annual Meeting”) was convened and adjourned, without any business being conducted...
NEW HAVEN, Conn., June 12, 2024 (GLOBE NEWSWIRE) -- Management of specialty cancer diagnostics company Precipio, Inc. (NASDAQ: PRPO) is requesting that shareholders instruct their brokers to vote their shares immediately today no later than 11pm Eastern Time. In order to e...